| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |